Why the study?
Does an aptamer-based biosensor accurately detect Troponin I in human samples for the diagnosis of myocardial infarction?
Does an aptamer-based biosensor accurately detect Troponin I in human samples for the diagnosis of myocardial infarction?
Answers are grounded in this paper and cite their sources.
The developed aptamer-based biosensor provides rapid, label-free detection of cardiac troponin I with high sensitivity and specificity, offering a potential tool for early diagnosis of myocardial infarction.
BACKGROUND: Acute myocardial infarction (MI) accounts for one third of deaths. Cardiac troponin I (TnI) is a reliable biomarker of cardiac muscle tissue injury and is employed in the early diagnosis of MI. OBJECTIVE: In this study, a molecular method is introduced to early diagnosis of MI by rapid detection of TnI. MATERIALS AND METHODS: The detection method was based on electrochemical aptasensing, being developed using different methods and evaluation steps. A gold electrode was used as a transducer to successful immobilize 76base aptamer to fabricate a TnI biosensor. RESULTS: The designed aptasensor could detect TnI in a range of 0.03 to 2.0 ng mL-1 without using any label, pre-concentration or amplification steps. The limit of detection was attained as 10 pg mL-1 without significant trouble of interfering species. The TnI biosensor demonestrated a stable, regenerative and reproducible function. 89 human samples were used to evaluate the performance of the TnI biosensor, and it represented 100% and 81%, diagnostic sensitivity and specificity, respectively. CONCLUSION: This aptasensor may be used as an applicable tool in the future of early medical diagnosis of MI.
No takes yet. Share an insight, caveat, or question.
Negahdary et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: